US EditionPublished • loading... • Updated
Xtant Medical Announces Commercial Launch of CollagenX™ – Ortho Spine News
Launch further expands Xtant’s biologics product portfolio to include surgical wound closure BELGRADE, Mont., Nov. 5, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced the commercial launch of CollagenX, its bovine collagen particulate product for surgical wound closure designed
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Xtant Medical Announces Commercial Launch of CollagenX™ – Ortho Spine News
Launch further expands Xtant’s biologics product portfolio to include surgical wound closure BELGRADE, Mont., Nov. 5, 2025 /PRNewswire/ — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced the commercial launch of CollagenX, its bovine collagen particulate product for surgical wound closure designed
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
